Denise Gavin

Title: The Innovative Contributions of Denise Gavin

Introduction

Denise Gavin is a notable inventor based in Silver Spring, MD (US). He has made significant contributions to the field of viral vector production, particularly through his innovative patent related to temperature-sensitive adeno-associated virus proteins.

Latest Patents

Denise Gavin holds a patent titled "Temperature-sensitive regulation of viral vector production." This invention provides temperature-sensitive (ts) adeno-associated virus (AAV) Rep78 and Rep68 proteins. In preferred embodiments, the ts AAV Rep78 and Rep68 proteins have missense mutations at amino acid positions 40, 42, and 44 that confer a temperature-sensitive phenotype. The patent also includes nucleotide sequences and vectors encoding the inventive ts Rep proteins. Additionally, it describes a hybrid adenovirus vector that stably comprises a nucleotide sequence encoding a ts AAV Rep protein according to the invention. The present invention further provides methods of packaging AAV vectors and methods of ex vivo gene delivery using the ts Rep proteins. Moreover, it includes cells containing the ts AAV Rep proteins, preferably stably integrated into the genome of the cell.

Career Highlights

Denise Gavin is affiliated with the University of North Carolina at Chapel Hill, where he continues to advance research in the field of gene therapy and viral vector technology. His work has implications for various applications in medicine and biotechnology.

Collaborations

Denise has collaborated with notable colleagues such as Richard Jude Samulski and Corinne Abernathy, contributing to the advancement of research in viral vectors and gene delivery systems.

Conclusion

Denise Gavin's innovative work in temperature-sensitive viral vector production showcases his significant contributions to biotechnology and gene therapy. His patent reflects a commitment to advancing scientific knowledge and improving therapeutic techniques.